These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5359270)

  • 1. [3 years' experience with depot fluphenazine].
    Horn HJ
    Med Klin; 1969 Nov; 64(48):2247-51. PubMed ID: 5359270
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of stupor states with flufenazine (Lyogen)].
    Korzeniowski L; Puzyński S
    Przegl Lek; 1968; 24(4):437-41. PubMed ID: 5671746
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience with fluphenazine Depot].
    Vencovský E; Sedivec V; Peterová E; Baudis P; Dvoráková M
    Act Nerv Super (Praha); 1970 Jan; 12(1):49-50. PubMed ID: 5418656
    [No Abstract]   [Full Text] [Related]  

  • 4. [Characteristics of the psychotropic activity of long-acting drugs (experience in the use of Moditen-depot)].
    Smulevich AB; Minsker EI; Mazaeva NA; Volkova RP; Lukanina SK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):912-20. PubMed ID: 5050051
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical therapeutic experiences with fluphenazine].
    Pfeiffer WM
    Arzneimittelforschung; 1967 Oct; 17(10):1327-9. PubMed ID: 5632888
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
    Tsutsul'kovskaia MIa; Minsker EI; Panteleeva GP; Mazurskii MB; Pekunova LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):753-8. PubMed ID: 4718619
    [No Abstract]   [Full Text] [Related]  

  • 7. Our experience with Moditene-Depot in chronic schizophrenia.
    Gamkrelidze ShA; Putkoradze-Gamkrelidze NA
    Act Nerv Super (Praha); 1973 Aug; 15(3):169. PubMed ID: 4769133
    [No Abstract]   [Full Text] [Related]  

  • 8. [Policlinical schizophrenia therapy with longtime neuroleptic agent fluphenazine decanoate].
    Haase HJ; Steuer A; Knaack M
    Med Welt; 1973 Feb; 24(8):306-7. PubMed ID: 4688219
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of the effects of fluphenazine-depot and flupenthixol-depot in the treatment of schizophrenic psychoses].
    Bilikiewicz A; Sep-Kowalikowa B
    Psychiatr Pol; 1976; 10(4):359-66. PubMed ID: 981411
    [No Abstract]   [Full Text] [Related]  

  • 10. Early hospital experience with fluphenazine decanoate.
    Small JG; Kellams J
    Dis Nerv Syst; 1974 Oct; 35(10):453-6. PubMed ID: 17894058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience with depot neuroleptic treatment].
    Waldmann KD; Neumann J
    Z Arztl Fortbild (Jena); 1984; 78(20):853-6. PubMed ID: 6523910
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with fluphenazine decanoate in psychoses].
    Náhunek K; Rodová A; Svestka J
    Act Nerv Super (Praha); 1970 Jan; 12(1):47-9. PubMed ID: 5460564
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical observations on the use of a long-acting phenothiazine (fluphenazine enanthate) in chronic schizophrenics.
    Christodoulidis H
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):311-5. PubMed ID: 4208347
    [No Abstract]   [Full Text] [Related]  

  • 14. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
    Levine J; Schooler NR; Severe J; Escobar J; Gelenberg A; Mandel M; Sovner R; Steinbook R
    Adv Biochem Psychopharmacol; 1980; 24():483-93. PubMed ID: 6996445
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychiatric pharmacotherapy and the schizophrenic defect.
    Molcan J; Floreánová L; Novotný V; Polák L; Rakús A; Motýlová A
    Act Nerv Super (Praha); 1973 May; 15(2):91. PubMed ID: 4148088
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neuroleptic depot treatment of chronic psychoses with fluphenazine-dekanoate].
    Weiser G; Gattringer B; Bengesser G
    Wien Med Wochenschr; 1973 Apr; 123(14):227-30. PubMed ID: 4695598
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
    Zhang YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical significance of depot fluphenazine decanoate in therapy of acute psychotic disorders].
    Ngui PW
    Seishin Shinkeigaku Zasshi; 1983; 85(9):635-9. PubMed ID: 6676769
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prognostic significance of selected side effects occurring in the course of prolonged-action fluphenazine treatment].
    Koślacz A; Popkowska N; Kulesza E; Lysikowska-Prokop L; Marmurowska-Michalowska H; Perzyński J
    Psychiatr Pol; 1977; 11(2):159-64. PubMed ID: 887674
    [No Abstract]   [Full Text] [Related]  

  • 20. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W
    Med Welt; 1970 Oct; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.